Novel α-Microspheres Potentiate Radioembolization for Liver Cancer via Synergistic Vascular Disruption and Self-Powered Cerenkov Photodynamic Therapy

Transarterial radioembolization (TARE) with β-emitting microspheres such as 90 Y serves as standard palliative care for advanced hepatocellular carcinoma (HCC), yet embolism-triggered intratumoral hypoxia confers radioresistance and limits therapeutic efficacy. Unlike β-rays, α-particles possess ultra-high linear energy transfer (LET) and oxygen-independent cytotoxicity, allowing efficient elimination of hypoxic tumor cells. Herein, we fabricated α-emitting 223 Ra-labeled chitosan/calcium phosphate microspheres (denoted 223 Ra-Chi/CaP MS). Capitalizing on the potent hypoxia-insensitive cytotoxicity of α-particles, these microspheres eradicate perivascular tumor cells and disrupt tumor vascular endothelium. To further eliminate tumor cells located distally from the vasculature, the microspheres were loaded with the photosensitizer methylene blue (MB) to harness Cerenkov photons emitted from the 223 Ra decay chain and achieve Cerenkov radiation-induced photodynamic therapy (CR-PDT), thereby expanding the therapeutic reach. The resulting 223 Ra-Chi/CaP-MB MS exhibited excellent physicochemical stability, sustained MB release, and prolonged tumor retention following hepatic artery delivery. In vitro studies demonstrated that the synergistic action of 223 Ra and CR-PDT triggered extensive DNA double-strand breaks and robust ROS generation, leading to enhanced apoptosis even under hypoxic conditions. In a rat orthotopic liver tumor model, TARE using 223 Ra-Chi/CaP-MB MS exerted more potent tumor growth inhibition than embolization controls or plain 223 Ra-Chi/CaP MS, predominantly through disrupting tumor blood vessels, blocking compensatory angiogenesis, and triggering extensive tumor cell apoptosis. With confirmed biosafety, this 223 Ra-based microsphere platform represents a transformative strategy to revitalize TARE for β-refractory liver cancer.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11636697/v1
Primary Topic
Radiopharmaceutical Chemistry and Applications
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Novel α-Microspheres Potentiate Radioembolization for Liver Cancer via Synergistic Vascular Disruption and Self-Powered Cerenkov Photodynamic Therapy

李闻捷, Jinming Tian, Yelin WU, Jiaojiao Li et al.
7 links
Research Square
Radiopharmaceutical Chemistry and Applications
preprint

Novel α-Microspheres Potentiate Radioembolization for Liver Cancer via Synergistic Vascular Disruption and Self-Powered Cerenkov Photodynamic Therapy

李闻捷, Jinming Tian, Yelin WU, Jiaojiao Li, Tongyao Hu, Qifan Xu, Yuqiao Wang, Xiao Li, Changjing Zuo, Weiwei Su, Tao Wang, Chao Cheng
preprint en

Abstract

Transarterial radioembolization (TARE) with β-emitting microspheres such as 90 Y serves as standard palliative care for advanced hepatocellular carcinoma (HCC), yet embolism-triggered intratumoral hypoxia confers radioresistance and limits therapeutic efficacy. Unlike β-rays, α-particles possess ultra-high linear energy transfer (LET) and oxygen-independent cytotoxicity, allowing efficient elimination of hypoxic tumor cells. Herein, we fabricated α-emitting 223 Ra-labeled chitosan/calcium phosphate microspheres (denoted 223 Ra-Chi/CaP MS). Capitalizing on the potent hypoxia-insensitive cytotoxicity of α-particles, these microspheres eradicate perivascular tumor cells and disrupt tumor vascular endothelium. To further eliminate tumor cells located distally from the vasculature, the microspheres were loaded with the photosensitizer methylene blue (MB) to harness Cerenkov photons emitted from the 223 Ra decay chain and achieve Cerenkov radiation-induced photodynamic therapy (CR-PDT), thereby expanding the therapeutic reach. The resulting 223 Ra-Chi/CaP-MB MS exhibited excellent physicochemical stability, sustained MB release, and prolonged tumor retention following hepatic artery delivery. In vitro studies demonstrated that the synergistic action of 223 Ra and CR-PDT triggered extensive DNA double-strand breaks and robust ROS generation, leading to enhanced apoptosis even under hypoxic conditions. In a rat orthotopic liver tumor model, TARE using 223 Ra-Chi/CaP-MB MS exerted more potent tumor growth inhibition than embolization controls or plain 223 Ra-Chi/CaP MS, predominantly through disrupting tumor blood vessels, blocking compensatory angiogenesis, and triggering extensive tumor cell apoptosis. With confirmed biosafety, this 223 Ra-based microsphere platform represents a transformative strategy to revitalize TARE for β-refractory liver cancer.

Research Square
Tongji University (CN), Xuzhou Medical College (CN), Second Military Medical University (CN), Chinese Academy of Sciences (CN), Shanghai East Hospital (CN)
National Natural Science Foundation of China, Chinese Academy of Sciences, Major Research Plan
Good health and well-being
Radiopharmaceutical Chemistry and Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon